Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3-chloro-5-(3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo(1,2-a)pyridine-3-spiro-4'-piperidino)propyl)-10,11-dihydro-5h-dibenz(b,f)azepine
2. Y 516
3. Y-516
1. 89419-40-9
2. Clospipramine
3. Mosapramine [inn]
4. Mosapramine (hydrochloride)
5. 04uzq7o9sj
6. Clospipramine (hydrochloride)
7. Mosapramine (inn)
8. 1'-[3-(3-chloro-10,11-dihydro-5h-dibenzo[b,f]azepin-5-yl)propyl]hexahydro-2h-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-2-one
9. Ncgc00183853-01
10. Mosapramine Hydrochloride [jan]
11. 1'-(3-(3-chloro-10,11-dihydro-5h-dibenzo[b,f]azepin-5-yl)propyl)hexahydro-2h-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-2-one
12. Unii-04uzq7o9sj
13. Mosapramine [mi]
14. Dsstox_cid_28772
15. Dsstox_rid_83041
16. Mosapramine [mart.]
17. Dsstox_gsid_48846
18. Mosapramine [who-dd]
19. 1'-[3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]spiro[1,5,6,7,8,8a-hexahydroimidazo[1,2-a]pyridine-3,4'-piperidine]-2-one
20. Schembl147139
21. Chembl2106650
22. Dtxsid0048846
23. Chebi:135775
24. Chebi:166972
25. 4,4-dichlorodiphenylsulfide
26. Tox21_113329
27. Bdbm50530438
28. Akos016014037
29. Db13676
30. Cas-89419-40-9
31. Hy-106584
32. Cs-0026106
33. D08235
34. L004956
35. Q6144116
36. (+-)-1'-(3-(3-chloro-10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl)hexahydrospiro(imidazo(1,2-a)pyridine-3(2h),4'-piperidin)-2-one
37. (+/-)-1'-(3-(3-chloro-10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl)hexahydrospiro(imidazo(1,2-a)pyridine-3(2h),4'-piperidin)-2-one
38. (- )-1'-(3-(3-chloro-10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl)hexahydrospiro(imidazo(1,2-a)pyridine-3(2h),4'-piperidin)-2-one.
| Molecular Weight | 479.1 g/mol |
|---|---|
| Molecular Formula | C28H35ClN4O |
| XLogP3 | 5.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 478.2499394 g/mol |
| Monoisotopic Mass | 478.2499394 g/mol |
| Topological Polar Surface Area | 38.8 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 725 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
N - Nervous system
N05 - Psycholeptics
N05A - Antipsychotics
N05AX - Other antipsychotics
N05AX10 - Mosapramine
Market Place
ABOUT THIS PAGE
92
PharmaCompass offers a list of Mosapramine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mosapramine manufacturer or Mosapramine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mosapramine manufacturer or Mosapramine supplier.
PharmaCompass also assists you with knowing the Mosapramine API Price utilized in the formulation of products. Mosapramine API Price is not always fixed or binding as the Mosapramine Price is obtained through a variety of data sources. The Mosapramine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mosapramine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mosapramine, including repackagers and relabelers. The FDA regulates Mosapramine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mosapramine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mosapramine supplier is an individual or a company that provides Mosapramine active pharmaceutical ingredient (API) or Mosapramine finished formulations upon request. The Mosapramine suppliers may include Mosapramine API manufacturers, exporters, distributors and traders.
Mosapramine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mosapramine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mosapramine GMP manufacturer or Mosapramine GMP API supplier for your needs.
A Mosapramine CoA (Certificate of Analysis) is a formal document that attests to Mosapramine's compliance with Mosapramine specifications and serves as a tool for batch-level quality control.
Mosapramine CoA mostly includes findings from lab analyses of a specific batch. For each Mosapramine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mosapramine may be tested according to a variety of international standards, such as European Pharmacopoeia (Mosapramine EP), Mosapramine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mosapramine USP).
